IOVA compared with LION: revenue, margins and what each company keeps, and the suppliers and customers both name

IOVAIovance Biotherapeutics, Inc.

Mkt capRevenueRevenue

LIONLionsgate Studios Corp.

Mkt capRevenueRevenue

Compare

IOVAIovance Biotherapeutics, Inc.

LIONLionsgate Studios Corp.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

IOVA

3 of 4at or beyond implied

Reportimpliedrealized× implied

Aug 6 '26±17.9%▲+43.09%×2.41

May 7 '26±16.0%▼−13.20%×0.82

Feb 24 '26±19.1%▲+30.80%×1.61

Nov 6 '25±27.6%▲+27.62%×1.00

LION

1 of 4at or beyond implied

Reportimpliedrealized× implied

Aug 7 '26±9.7%▲+0.31%×0.03

May 22 '26±13.0%▲+15.80%×1.22

= impliedIOVA realized, solidLION realized, hatchedOne scale, both sides: full bar = 44%× = |realized| ÷ impliedSource: market data

Feb 6 '26

±12.1%

▲+2.49%

×0.21

Nov 7 '25±13.0%▼−2.28%×0.18

IOVAIovance Biotherapeutics, Inc.

8.47▼−11.40%· post 8.45

Mkt cap$3.8BRevenue$99MQ2 FY26Revenue$264MFY25

LIONLionsgate Studios Corp.

12.48▼−2.89%· post 12.48

ClosedOct 30 '26

Mkt cap$3.6BRevenue$777MQ1 FY27Revenue—

Compare

ClosedOct 30 '26

IOVAIovance Biotherapeutics, Inc.

LIONLionsgate Studios Corp.

8.47▼−11.40%post 8.45

Price

12.48▼−2.89%post 12.48

$3.8B

Mkt cap

$3.6B

Q2 FY26$99M

Revenue

$777MQ1 FY27

FY25$264M

Revenue

—

IOVA8.47▼−11.40%vsLION12.48▼−2.89%ClosedOct 30 '26